Adenovirus-expressed preS2 antibody inhibits hepatitis B virus infection and hepatic carcinogenesis

doi:10.3748/wjg.v18.i4.349

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3335)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

307

HTML

2533

Figures (1-3)

298

Tables (1-1)

197

Sum=3335

Jan 28, 2012 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jan 28, 2012; 18(4): 349-355
Published online Jan 28, 2012. doi: 10.3748/wjg.v18.i4.349

Full Size Figure Download Figure

Figure 2 Inhibitory effects of the Ad315-preS2Ab-mediated preS2Ab against hepatitis B virus infection. ELISA results show HBsAg secretion in the supernatants of L02 cells infected with Ad315-preS2Ab. The inhibition of HBV infections increases with increasing Ad315-preS2Ab MOIs, as shown by decreases in HBsAg (P < 0.05). Cells infected with the Ad315 blank vector show no inhibitory effects against HBV infection. ELISA: Enzyme linked immunosorbent assay; HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; MOI: Multiplicity of infection.

Citation: Zhang Q, Li ZQ, Liu H, Yang JH. Adenovirus-expressed preS2 antibody inhibits hepatitis B virus infection and hepatic carcinogenesis. World J Gastroenterol 2012; 18(4): 349-355
URL: https://www.wjgnet.com/1007-9327/full/v18/i4/349.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i4.349